The first Kaleido Biosciences trade was made in Q1 2021.
Since then Jim Simons bought shares three more times and sold shares on two occasions. The investor sold all their shares in Q2 2022 and doesn't own any shares in Kaleido Biosciences anymore.
Avg closing price
Price range
Sold -86.9 Thousand shares
Q2 2022
Avg closing price
$0.91
Price range
$0.17
-
$1.70
Increased shares by 120.7% (+47.5 Thousand shares)
Q1 2022
Avg closing price
$1.78
Price range
$1.30
-
$2.70
Increased shares by 32.1% (+9.57 Thousand shares)
Q4 2021